Therapeutic potential of stem cells in diabetes.

@article{Roche2006TherapeuticPO,
  title={Therapeutic potential of stem cells in diabetes.},
  author={Enrique Roche and Roberto Ense{\~n}at-Waser and Juan Antonio Reig and J M Jones and Trinidad Le{\'o}n-Quinto and Bernat Soria},
  journal={Handbook of experimental pharmacology},
  year={2006},
  volume={174},
  pages={
          147-67
        }
}
Stem cells possess the ability to self-renew by symmetric divisions and, under certain circumstances, differentiate to a committed lineage by asymmetric cell divisions. Depending on the origin, stem cells are classified as either embryonic or adult. Embryonic stem cells are obtained from the inner cell mass of the blastocyst, a structure that appears during embryonic development at day 6 in humans and day 3.5 in mice. Adult stem cells are present within tissues of adult organisms and are… Expand
Critical issues for engineering cord blood stem cells to produce insulin
TLDR
The challenges ahead demand detailed understanding of molecular mechanisms to move from an opportunistic, phenotypic approach to transplantation and amelioration of blood glucose, to an orderly and logical approach to a biologically and medically meaningful solution. Expand
Safety and efficacy of embryonic stem cell microenvironment in a leukemia mouse model.
TLDR
Inducing the suicide gene at the appropriate time can reduce or even avoid tumorigenicity and immune rejection after transplantation of ESCs in vivo and improve the safety of their clinical application. Expand
Directed engineering of umbilical cord blood stem cells to produce C‐peptide and insulin
TLDR
These results are the first demonstration that human umbilical cord blood‐derived stem cells can be engineered to engage in de novo synthesis of insulin. Expand
The effect of in vivo mobilization of bone marrow stem cells on the pancreas of diabetic albino rats (a histological & immunohistochemical study).
TLDR
Aphanizomenon flos-aquae plant extract points to the significant role of StemEnhance in stem cell mobilization and the improvement of diabetes mellitus. Expand
Efficacy of renal precursor stem cells in management of chronic kidney disease : a cohort study
In spite of tremendous achievements of modern medical science, chronic kidney disease (CKD) is still considered to be an untreatable pathology. CKD is caused by various etiological factors and isExpand
Diabetic neuropathy in children and adolescents with type 1 diabetes mellitus: Diagnosis, pathogenesis, and associated genetic markers
TLDR
A number of recently identified genes, including the AKR1B1, VEGF, MTHFR, APOE, and ACE genes, contribute significantly in the pathogenesis of DN and may serve as biomarkers to predict future DN development or treatment response. Expand
New insights in diabetic autonomic neuropathy in children and adolescents.
TLDR
Cardiovascular autonomic neuropathy is the most clinically important and well-studied form of DAN and no form of therapy in DAN has been identified that provides unequivocal, safe, and effective stabilization or reversal of the condition. Expand
Diabetic cardiovascular autonomic neuropathy: clinical implications
TLDR
A regular, more generalized and multifactorial approach should be adopted with inclusion of lifestyle modifications, strict glycemic control and treatment of concomitant traditional cardiovascular risk factors, in order to achieve the best therapeutic results. Expand